131I-Tositumomab Therapy as Initial Treatment for Follicular Lymphoma
Volume: 352, Issue: 5, Pages: 441 - 449
Published: Feb 3, 2005
Abstract
Advanced-stage follicular B-cell lymphoma is considered incurable. Anti-CD20 radioimmunotherapy is effective in patients who have had a relapse after chemotherapy or who have refractory follicular lymphoma, but it has not been tested in previously untreated patients.Seventy-six patients with stage III or IV follicular lymphoma received as initial therapy a single course of treatment with 131I-tositumomab therapy (registered as Tositumomab and...
Paper Details
Title
131I-Tositumomab Therapy as Initial Treatment for Follicular Lymphoma
Published Date
Feb 3, 2005
Volume
352
Issue
5
Pages
441 - 449
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History